NCT07232719 A Study of Retatrutide (LY3437943) in Participants With Obesity or Overweight Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT07231952 A Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL) Status RECRUITING Phase PHASE2
NCT07226843 A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers Status RECRUITING Phase PHASE1
NCT07225556 A Study of LY4167586 in Participants With Obesity or Overweight Who Are Otherwise Healthy Status RECRUITING Phase PHASE1
NCT07223840 A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid Relapse Status RECRUITING Phase PHASE2
NCT07223593 Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease Status RECRUITING Phase PHASE3
NCT07222332 A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE) Status RECRUITING Phase PHASE3
NCT07222137 A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults Status RECRUITING Phase PHASE3
NCT07219966 A Study of Brenipatide in Participants With Moderate-to-Severe Alcohol Use Disorder Status RECRUITING Phase PHASE3
NCT07219953 A Study of Brenipatide in Participants With Alcohol Use Disorder Status RECRUITING Phase PHASE3
NCT07219173 A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma Status RECRUITING Phase PHASE2
NCT07218380 A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract Status RECRUITING Phase PHASE3
NCT07218341 A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Status RECRUITING Phase PHASE4
NCT07215559 A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes Status RECRUITING Phase PHASE2
NCT07215312 A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated With Basal Insulin Status RECRUITING Phase PHASE2
NCT07213804 A Two-Part Phase 3 Study of Sofetabart Mipitecan (LY4170156) in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Part B) Ovarian Cancer Status RECRUITING Phase PHASE3
NCT07213791 A Study of LY4337713 in Participants With FAP-Positive Solid Tumors Status RECRUITING Phase PHASE1
NCT07202884 A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight Status RECRUITING Phase PHASE3